Polyrizon (PLRZ): היקף יתרות המזומנים של החברה

Polyrizon Ltd creates unique nasal gels, avoiding price wars through physical barriers. The cash volume dynamics demonstrate the market valuation of liquidity, where 0.01 determines the current value of the indicator. The development of drug delivery systems is proceeding through laboratory partnerships, however, geopolitical risks and raw material supply disruptions remain critical factors for the holding.
פילוחים אנליטיים של חברת Polyrizon (PLRZ)

This indicator tracks the daily liquid asset balance, eliminating the time gaps inherent in standard reporting. The metric determines the business's current margin of safety, balancing default risk against capital efficiency. For Polyrizon Ltd (PLRZ), such reserves are critical when scaling innovative nasal sprays. The medical community's trust requires stable funding for research and development. By analyzing changes in cash on hand, an investor assesses the biotech company's ability to sustain its operational activities.